Soliris 300 MG/30 ML vial 30ML
Ended Awarded
- Contract number
- SPE2DX25F6AEY
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $15,068
Award facts
- Contract value 100% obligated
- $15,068.19 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $15,068.19 for SOLIRIS 300 mg/30 ml vials on September 2, 2025. This firm fixed-price delivery order, which is expected to be completed by September 23, 2025, was issued by the Defense Logistics Agency's Medical Supply Chain division without a set-aside designation. The award represents a specific product delivery under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB program, a $499.9 billion vehicle valid through November 2026 that enables the agency to procure a comprehensive range of pharmaceutical products for military health facilities worldwide.
SOLIRIS is a biologic medication used to treat rare blood disorders and complement-mediated diseases, and this delivery order fulfills a specific medical supply need for Department of Defense healthcare sites. DMS Pharmaceutical Group has demonstrated sustained capability as a critical supplier in the federal pharmaceutical supply chain, with a robust portfolio of delivery orders covering prescription medications, biologics, vaccines, and specialty pharmaceutical products. The company's positioning as a woman-owned small business has enabled it to compete effectively in federal procurement markets while maintaining significant distribution relationships across military and federal healthcare facilities nationwide.
Quick answers
Who was awarded contract SPE2DX25F6AEY?
SPE2DX25F6AEY was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on September 2, 2025.
How much is contract SPE2DX25F6AEY worth?
The government has obligated $15,068 on SPE2DX25F6AEY.
Is contract SPE2DX25F6AEY an order under another contract?
Yes. SPE2DX25F6AEY is a delivery order under SPE2DX15D9114, an indefinite delivery contract.
Was contract SPE2DX25F6AEY competed?
The extent of competition for SPE2DX25F6AEY was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award